Inhaled mannitol for the treatment of cystic fibrosis (Q37979246)

26 August 2017

Inhaled mannitol for the treatment of cystic fibrosis (English)

1 reference

26 August 2017

0 references

1 reference

Katharine Hurt

1

1 reference

PubMed ID

22283575

26 August 2017

Diana Bilton

series ordinal

2

1 reference

26 August 2017

1 February 2012

1 reference

Expert Review of Respiratory Medicine

26 August 2017

1 reference

26 August 2017

6

1 reference

26 August 2017

1

1 reference

26 August 2017

19-26

1 reference

Management of pulmonary disease in patients with cystic fibrosis

26 August 2017

1 reference

Incidence, population, and survival of cystic fibrosis in the UK, 1968-95. UK Cystic Fibrosis Survey Management Committee

21 January 2018

1 reference

Evidence for airway surface dehydration as the initiating event in CF airway disease

21 January 2018

1 reference

21 January 2018

1 reference

Update on pathogenesis of cystic fibrosis lung disease

21 January 2018

1 reference

Finally, mice with CF lung disease

21 January 2018

1 reference

Increased airway epithelial Na+ absorption produces cystic fibrosis-like lung disease in mice

21 January 2018

1 reference

21 January 2018

1 reference

Defense Mechanisms of the Lungs

21 January 2018

1 reference

In vivo effects of recombinant human DNase I on sputum in patients with cystic fibrosis

21 January 2018

1 reference

Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. The Pulmozyme Study Group

21 January 2018

1 reference

A two-year randomized, placebo-controlled trial of dornase alfa in young patients with cystic fibrosis with mild lung function abnormalities

21 January 2018

1 reference

Clinical use of dornase alpha is associated with a slower rate of FEV1 decline in cystic fibrosis.

21 January 2018

1 reference

Improved survival at low lung function in cystic fibrosis: cohort study from 1990 to 2007.

21 January 2018

1 reference

Inhaled medication and inhalation devices for lung disease in patients with cystic fibrosis: A European consensus

21 January 2018

1 reference

A controlled trial of long-term inhaled hypertonic saline in patients with cystic fibrosis

21 January 2018

1 reference

Evaluation of ventilation maldistribution as an early indicator of lung disease in children with cystic fibrosis.

21 January 2018

1 reference

Multiple-breath inert gas washout and spirometry versus structural lung disease in cystic fibrosis.

21 January 2018

1 reference

Denufosol tetrasodium in patients with cystic fibrosis and normal to mildly impaired lung function

21 January 2018

1 reference

Comparison of mannitol and methacholine to predict exercise-induced bronchoconstriction and a clinical diagnosis of asthma

21 January 2018

1 reference

The safety and efficacy of inhaled dry powder mannitol as a bronchial provocation test for airway hyperresponsiveness: a phase 3 comparison study with hypertonic (4.5%) saline

21 January 2018

1 reference

Goblet cells secretion and mucogenesis

21 January 2018

1 reference

Pharmacological approaches to discovery and development of new mucolytic agents

21 January 2018

1 reference

Sodium chloride increases the ciliary transportability of cystic fibrosis and bronchiectasis sputum on the mucus-depleted bovine trachea

21 January 2018

1 reference

Evidence of mast cell activation and leukotriene release after mannitol inhalation

21 January 2018

1 reference

The effect of inhaled mannitol on bronchial mucus clearance in cystic fibrosis patients: a pilot study

21 January 2018

1 reference

The 24-h effect of mannitol on the clearance of mucus in patients with bronchiectasis

21 January 2018

1 reference

Effect of mannitol and repetitive coughing on the sputum properties in bronchiectasis

21 January 2018

1 reference

Effect of increasing doses of mannitol on mucus clearance in patients with bronchiectasis

21 January 2018

1 reference

Inhaled mannitol for the treatment of mucociliary dysfunction in patients with bronchiectasis: effect on lung function, health status and sputum

21 January 2018

1 reference

Inhaled mannitol improves lung function in cystic fibrosis.

21 January 2018

1 reference

Inhaled mannitol improves the hydration and surface properties of sputum in patients with cystic fibrosis

21 January 2018

1 reference

Comparison of inhaled mannitol, daily rhDNase and a combination of both in children with cystic fibrosis: a randomised trial

21 January 2018

1 reference

Bronchial provocation testing with dry powder mannitol in children with cystic fibrosis

21 January 2018

1 reference

Plant host and sugar alcohol induced exopolysaccharide biosynthesis in the Burkholderia cepacia complex

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1586/ERS.11.87

1 reference

26 August 2017

1 reference

PubMed ID

22283575